Las cookies nos ayudan a ofrecer nuestros servicios. Al utilizar nuestros servicios, aceptas el uso de cookies.

Editorial Cuvillier

Publicaciones, tesis doctorales, capacitaciónes para acceder a una cátedra de universidad & prospectos.
Su editorial internacional especializado en ciencias y economia

Editorial Cuvillier

De En Es
Predicting Oral Absorption of Poorly Soluble Weakly Basic Drugs

Impresion
EUR 52,90

E-Book
EUR 37,03

Predicting Oral Absorption of Poorly Soluble Weakly Basic Drugs (Tienda española)

Mark Berlin (Autor)

Previo

Indice, PDF (60 KB)
Lectura de prueba, PDF (260 KB)

ISBN-13 (Impresion) 9783736991460
ISBN-13 (E-Book) 9783736981461
Idioma Inglés
Numero de paginas 248
Laminacion de la cubierta mate
Edicion 1. Aufl.
Lugar de publicacion Göttingen
Lugar de la disertacion Frankfurt am Main
Fecha de publicacion 08.12.2015
Clasificacion simple Tesis doctoral
Area Tecnología farmaceútica
Palabras claves Weak base, Dissolution, Supersaturation, Precipitation, Gastric emptying, Food effects, IVIVC, PBPK modeling
Descripcion

This book deals with predicting behavior of poorly soluble weakly basic drugs in the human body, particularly in the gastrointestinal tract. Under fasting conditions weak bases usually show good solubility in the human stomach and poor solubility in the intestine. This solubility discrepancy can lead to unusual drug dissolution behavior during the process of gastric emptying, such as supersaturation and precipitation. The current thesis investigates dissolution, supersaturation and precipitation behavior of weak bases in the human stomach and intestine using biorelevant media. These media simulate fluids of the gastrointestinal tract and can be utilized in different in vitro experiments mimicking the human gastric and intestinal physiology. The experimental outcomes can then be coupled with physiologically based pharmacokinetic (PBPK) models, which simulate drug uptake into the human blood flow and finally enable the prediction of drug plasma concentration profiles in humans. This work shows that combining biorelevant in vitro investigation with PBPK modeling is essential for predicting in vivo performance of poorly soluble weakly basic drugs.